Headline
The latest stories from AHA Today.
The Department of Health and Human Services today delayed until July 1, 2019 implementation of its final rule on 340B drug ceiling prices and civil monetary penalties for manufacturers.
Food and Drug Administration Commissioner Scott Gottlieb, M.D., yesterday shared an update on the agency’s work to mitigate shortages of intravenous drugs, shorten supply disruptions and better predict vulnerabilities.
Ninety-one percent of all clinicians eligible for the Merit-based Incentive Payment System participated in the first year of the Quality Payment Program.
The Food and Drug Administration this week issued a safety communication reminding health care professionals of factors that increase the risk of surgical fires on or near a patient and offering recommendations to reduce these fires from occurring.
Hospital and health system leaders are invited to apply for the AHA’s Health Care System Transformation Fellowship.
We believe it’s important for hospital and health system leaders to understand the trends and forces impacting the field, as well as the opportunities disruptive innovation may create. That’s why we’ve created a new home on AHA.org to track and analyze these trends.
The Food and Drug Administration yesterday provided an update on federal preparedness and the agency’s response efforts to the Ebola outbreak in the Democratic Republic of Congo.
The Substance Abuse and Mental Health Services Administration is accepting applications for $196 million to treat opioid use disorders through one of its grant programs.
The Food and Drug Administration today released two draft guidance documents aimed at reducing the ability of brand drug makers to use the agency’s Risk Evaluation and Mitigation Strategy programs as a way to block timely generic drug entry.
Virginia legislators yesterday voted to approve a budget bill that would expand access to Medicaid coverage to as many as 400,000 low-income residents.